Remedium Lifecare Ltd Share Price

Q: What is the share price of Remedium Lifecare Ltd today?

Remedium Lifecare Ltd share price as on 18 Nov 2025 is ₹1.39

Pharmaceuticals

BSE: 539561 Small Cap ISIN: INE549S01036

As on 18 November 2025 at 23:51 IST

₹1.39

-0.01

(-0.71%)

Sell Buy

Over 1 Month

-10.26%

Over 6 Months

-17.65%

Over 1 Year

-68.18%

Over 3 Years

59.09%

Remedium Lifecare Ltd Summary

Close ₹1.40

Open ₹1.51

High ₹1.51

Low ₹1.38

Volume 3,10,60,628

Net Turnover (in Cr) ₹4.4

52Wk High ₹4.40

52Wk Low ₹0.80

52Wk High / Low

0.80

4.40

Remedium Lifecare Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹123.48

EPS (TTM) -

Book Value (BV) 1.03

Div. Yield -

P/E (TTM) -140

Price/Book Value 1.35

Delivery % 80.40 %

Face Value 1

Key Ratios

PE Ratio 45.50

PB Ratio 1.70

EV to Sales 5.45

PEG Ratio -0.46

ROA 0.13

ROE 3.55

Debt-Equity 13.90

Net Profit Margin 0.69

Operating Profit Margin 5.10

Remedium Lifecare Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025
Total Revenue	416.05
Total Expenses	411.67
Profit Before Tax	4.38
Profit After Tax	2.13
Operating Profit After Depreciation	9.67

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025
Fixed Assets	0.01
Total Non Current Assets	0.04
Total Current Assets	1,720.30
Total Assets	1,720.35
Total Shareholder's Fund	43.89

Cash Flow

Particulars (in ₹ Cr.)	FY 2025
Net Cash From Operating Activities	-1,134.81
Net Cash Used In Investing Activities	0.13
Net Cash Used In Financing Activities	1,136.10

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	233.30	4,062.79	509.84	504.79	90.04
Total Expenses	229.64	4,012.33	502.44	503.27	89.38
Profit Before Tax	3.66	50.45	7.40	1.53	0.65
Profit After Tax	1.53	32.73	5.43	1.08	0.48
Operating Profit After Depreciation	8.95	54.33	7.32	1.63	0.65

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	0.01	0.05	0.08	0.19	0.21
Total Non Current Assets	0.11	0.07	0.09	0.19	0.21
Total Current Assets	1,539.54	1,947.85	1,154.14	223.57	38.32
Total Assets	1,539.65	1,947.92	1,154.22	223.76	38.53
Total Shareholder's Fund	43.30	42.96	10.36	4.94	3.86

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-1,078.63	-74.16	20.50	11.28	-10.21
Net Cash Used In Investing Activities	0.06	-	-0.04	-0.05	-0.04
Net Cash Used In Financing Activities	1,078.40	53.83	-0.04	-10.61	10.14

Particulars (in ₹ Cr.)	2025-06	2025-03
Total Revenue	113.37	264.32
Total Expenses	111.50	264.78
Profit Before Tax	5.71	-1.40
Profit After Tax	4.65	-2.05
Operating Profit after Depreciation	5.35	0.20

Particulars (in ₹ Cr.)	2025-06	2025-03	2024-12	2024-09	2024-06
Total Revenue	18.37	81.57	38.15	25.08	77.70
Total Expenses	22.58	82.75	43.63	20.62	77.31
Profit Before Tax	-0.37	-2.12	1.06	2.46	2.27
Profit After Tax	-0.37	-2.64	0.76	1.78	1.64
Operating Profit after Depreciation	-0.73	-0.52	1.95	5.28	2.28

Remedium Lifecare Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1.35

S2 1.30

S3 1.22

Pivot 1.43

R1 1.48

R2 1.56

R3 1.61

Moving Average

20 SMA 1.51

50 SMA 1.50

100 SMA 1.35

200 SMA 1.60

Remedium Lifecare Ltd Corporate Actions

No available data

AGM Date: 30 Sep 2021

Intimation of 32nd Annual General Meeting scheduled to be held on Thursday September 30 2021. Outcome / Proceedings of 32nd Annual General Meeting held on September 30 2021 (As Per BSE Announcement Dated on 9/30/2021 5:01:42 AM) E-Voting Result and Scrutinizer Report for the 32nd Annual General Meeting of the Company held on 30.09.2021 (As Per BSE Announcement Dated 01.10.2021)

AGM Date: 20 Sep 2022

AGM 20/09/2022 33rd Annual General Meeting (AGM) of the Company will be held on Tuesday, 20th September, 2022 at 10.00 am through VC/OAVM. Book Closure: From Wednesday 14th September, 2022 to Tuesday 20th September, 2022 (both days inclusive) (As Per BSE Announcement Dated on 26.08.2022) Annual Report for the F.Y. 2021-22. (As Per BSE Announcement Dated on 27.08.2022) Outcome of 33rd Annual General Meeting held on 20.09.2022 (As Per BSE Announcement Dated on 20.09.2022) Remedium Lifecare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Scrutinizer Report and E-Voting Result for the 33rd Annual General Meeting held on 20.09.2022 (As Per BSE Announcement Dated on 21.09.2022)

AGM Date: 20 Jul 2023

Remedium Lifecare Ltd has informed BSE that the Board of Directors of the Company at their meeting held on 23/06/2023 ,inter alia, had considered and approved the: 1. Issue of Bonus Shares to the existing Equity Shareholders of the Company. 2. Sub-division of Shares/ Stock Split of the Company. 3. Board recommendation for seeking enabling resolution for borrowing in excess of limit specified u/s 180(1)(c) of the Companies act 2013 subject to shareholders approval. Approved Draft Notice for convening the Annual General Meeting (AGM) for above purpose. An Annual General Meeting of the Company to be convened on Thursday, July 20, 2023 at 11.00 A.M., through Video Conferencing/ Other Audio Visual Means (OAVM) in compliance with the applicable provisions of the Companies Act, 2013 read with MCA General Circular No. 14/2020 dated 08.04.2020, General Circular No. 17/2020 dated 13.04.2020, General Circular No. 22/2020 dated 15.06.2020, General Circular No. 33/2020 dated 28.09.2020, General Circular No. 39/2020 dated 31.12.2020, General Circular No.10/2021dated 23.06.2021, General Circular No. 20/2021 dated 08.12.2021, General Circular No. 3/2022 dated 05.05.2022 and General Circular No. 10/2022 dated 28.12.2022 to transact the above business. (As Per BSE Bulletin dated on 23.06.2023) 34th Annual General Meeting (AGM) of the Company will be held on Thursday, 20th July, 2023 at 11.00 a.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM (As Per BSE Announcement Dated on 26.06.2023) Annual Report for the F.Y. 2022-23. (As Per BSE Announcement Dated on 27/06/2023) Newspaper Publication mentioning procedure of E-voting for the 34th AGM. (As Per BSE Announcement Dated on 28.06.2023) Outcome of 34th AGM held on 20.07.2023. Scrutinizer Report and E- Voting Result for 34th Annual General Meeting held on 20.07.2023. (As Per BSE Announcement dated on 20.07.2023) Regulations 30 and 44 read with Schedule III of SEBI LODR Regulations 2015 showing revised format of Voting Result alongwith Scrutinizer''s Report. (As per BSE Announcement Dated on 21/07/2023)

AGM Date: 26 Jun 2024

AGM 26/06/2024 We wish to inform you that the 35th Annual General Meeting (AGM) of the Company will be held on Wednesday, 26 June, 2024 at 11:00 AM (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM), in accordance with the circulars issued by the Ministry of Corporate Affairs (MCA) and Securities Exchange Board of India (SEBI). As per Regulation 34 (1) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the Financial Year 2023-24 along with the Notice of the AGM. In accordance with the MCA Circulars and SEBI Circulars the same are being sent through electronic mode to those member's whose email id's are registered with Depository Participant / Registrar & Transfer Agent of the Company. Kindly take on record the above information and acknowledge Outcome of 35th Annual General Meeting of Remedium Lifecare Limited held on 26th June 2024 pursuant to Regulation 30 of SEBI (LODR) Regulations 2015. Outcome of 35th Annual General Meeting of Remedium Lifecare Limited held on 26th June 2024 pursuant to Regulation 30 of SEBI (LODR) Regulations 2015. (As per BSE Announcement Dated on 26/06/2024)

AGM Date: 24 Sep 2025

AGM 24/09/2025 36th Annual General Meeting of the company to be held on Wednesday, 24th September, 2025 at 11.00 a.m. through VC/OAVM (As per BSE Announcement Dated on 03.09.2025) Proceedings of 36th AGM held on 24.09.2025 through VC/OAVM e-voting results of AGM and scrutinizer Report of AGM held on 24.09.2025 through VC/OAVM (As Per BSE Announcement Dated on:24.09.2025)

Remedium Lifecare Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Remedium Lifecare Ltd Top Mutal Funds Invested

No data available

Remedium Lifecare Ltd News

Remedium Lifecare to convene board meeting

On 14 November 2025

07 Nov 2025, 10:57 am

Remedium Lifecare to hold board meeting

On 22 September 2025

17 Sep 2025, 10:11 am

Remedium Lifecare schedules AGM

On 24 September 2025

04 Sep 2025, 11:40 am

Remedium Lifecare to declare Quarterly Results

On 4 August 2025

31 Jul 2025, 11:32 am

Remedium Lifecare announces board meeting date

On 30 May 2025

28 May 2025, 03:50 pm

Remedium Lifecare Ltd Stock Analysis

Annual revenue for Remedium Lifecare Ltd decreased by 94.26% to ₹233.30 crore in FY 2025 from ₹4,062.79 crore in FY 2024.
Annual Net Profit for Remedium Lifecare Ltd decreased by 95.32% to ₹1.53 crore in FY 2025 from ₹32.73 crore in FY 2024.
Promoter Shareholding in Remedium Lifecare Ltd remains unchanged by 0.00% in the most recent quarter, from 1.13% in June 2025 to 1.13% in September 2025.
Remedium Lifecare Ltd delivered a 1-year return of -68.18% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Remedium Lifecare Ltd share price moved down by 0.71% from its previous close of INR ₹1.40. The latest Remedium Lifecare Ltd share price is INR ₹1.39.
Remedium Lifecare Ltd share price today has been at a low of 1.37 and a high of 1.43. Over the past 52 weeks, the Remedium Lifecare Ltd share price has seen a low of 0.80 and a high of 4.40.